Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| SMO | Q99835 | Protein smoothened (Protein Gx) | Cancer-related genesDisease related genesFDA approved drug targets | 7 | Basal cell carcinomaBrain cancerChronic myelomonocytic leukaemia | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.28 | ||
| SORC2 | Q96PQ0 | VPS10 domain-containing receptor SorCS2 [Cleaved into: SorCS2 122 kDa chain; SorCS2 104 kDa chain; SorCS2 18 kDa chain] | 1 | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.28 | ||||
| SORC3 | Q9UPU3 | VPS10 domain-containing receptor SorCS3 | 1 | Receptor-signaling mediation | 1 | 0.28 | ||||
| SORL | Q92673 | Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) | Disease related genesPlasma proteinsPotential drug targets | 1 | Alzheimer diseaseAmyloidosis | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation | 1 | 0.28 | ||
| SORT | Q99523 | Sortilin (100 kDa NT receptor) (Glycoprotein 95) (Gp95) (Neurotensin receptor 3) (NT3) (NTR3) | Disease related genesPotential drug targetsPredicted intracellular proteins | 1 | Frontotemporal dementiaMotor neuron diseaseNeurodegenerative disorder | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.28 | ||
| SPPL3 | Q8TCT6 | Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin homologous protein 1) (PSH1) (Presenilin-like protein 4) | EnzymesPredicted membrane proteins | 9 | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.28 | |||
| SR5A3 | Q9H8P0 | Polyprenal reductase (EC 1.3.1.94) (3-oxo-5-alpha-steroid 4-dehydrogenase 3) (EC 1.3.1.22) (Steroid 5-alpha-reductase 2-like) (Steroid 5-alpha-reductase 3) (S5AR 3) (SR type 3) | Disease related genesEnzymesHuman disease related genes | 6 | CataractCongenital disorder of glycosylationIntellectual disability | Clinical-translation mediationMetabolism mediation | 1 | 0.28 | ||
| SSR5 | P35346 | Somatostatin receptor type 5 (SS-5-R) (SS5-R) (SS5R) (SST5) | 7 | Alzheimer diseaseCushing syndromeStomach cancer | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.28 | |||
| STAB1 | Q9NY15 | Stabilin-1 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1) (FEEL-1) (MS-1 antigen) | Predicted membrane proteinsTransporters | 1 | Adhesion and uptake mediationFusion and delivery mediation | 1 | 0.28 | |||
| STEA4 | Q687X5 | Metalloreductase STEAP4 (EC 1.16.1.-) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9) | 6 | Fusion and delivery mediation | 1 | 0.28 |